First-line, long-term treatment of multiple myeloma with thalidomide, dexamethasone, and zoledronate in combination (TDZ)
Year: 2004
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: U. Klueppelberg, L. Chen, C. M. Aloba, J. Shapira, E. Smith, N. Palanisamy, J. Schmidt, M. Moezi, O. Batuman
Institution: SUNY Downstate Health Sciences University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2243209818
